ZA881122B - Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders - Google Patents
Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disordersInfo
- Publication number
- ZA881122B ZA881122B ZA881122A ZA881122A ZA881122B ZA 881122 B ZA881122 B ZA 881122B ZA 881122 A ZA881122 A ZA 881122A ZA 881122 A ZA881122 A ZA 881122A ZA 881122 B ZA881122 B ZA 881122B
- Authority
- ZA
- South Africa
- Prior art keywords
- agents
- substituted heterocyclic
- heterocyclic compounds
- treating coronary
- cerebral disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873705220 DE3705220A1 (de) | 1987-02-19 | 1987-02-19 | Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA881122B true ZA881122B (en) | 1989-10-25 |
Family
ID=6321287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA881122A ZA881122B (en) | 1987-02-19 | 1988-02-18 | Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0279357A2 (xx) |
JP (1) | JPS63222115A (xx) |
KR (1) | KR880009648A (xx) |
DE (1) | DE3705220A1 (xx) |
DK (1) | DK83688A (xx) |
HU (1) | HU200941B (xx) |
ZA (1) | ZA881122B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931464A (en) * | 1989-02-15 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
DE3926606A1 (de) * | 1989-08-11 | 1991-02-14 | Hoechst Ag | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
-
1987
- 1987-02-19 DE DE19873705220 patent/DE3705220A1/de not_active Withdrawn
-
1988
- 1988-02-11 EP EP88102013A patent/EP0279357A2/de not_active Withdrawn
- 1988-02-17 KR KR1019880001666A patent/KR880009648A/ko not_active Application Discontinuation
- 1988-02-18 HU HU88783A patent/HU200941B/hu not_active IP Right Cessation
- 1988-02-18 DK DK083688A patent/DK83688A/da not_active Application Discontinuation
- 1988-02-18 JP JP63036454A patent/JPS63222115A/ja active Pending
- 1988-02-18 ZA ZA881122A patent/ZA881122B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUT47222A (en) | 1989-02-28 |
DK83688A (da) | 1988-08-20 |
HU200941B (en) | 1990-09-28 |
JPS63222115A (ja) | 1988-09-16 |
KR880009648A (ko) | 1988-10-04 |
DK83688D0 (da) | 1988-02-18 |
DE3705220A1 (de) | 1988-09-01 |
EP0279357A2 (de) | 1988-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2157178B (en) | Apparatus for treating disorders of cardiac rhythm | |
EP0467164A3 (en) | Use of the compound flupirtine against muscle bracing | |
MY115431A (en) | Heterocyclic compounds for the treatment of cns and cardiovascular disorders | |
PT79220B (en) | Process for preparing new pyridoindole derivatives useful as agents for the treatment of diseases of the centrel nervous system | |
EP0179808A4 (en) | MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS. | |
JPS6448864A (en) | Continuous finish treatment for aqueous crude dye suspension | |
US4931457B1 (en) | Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders | |
YU238288A (en) | Process for obtaining substituted derivatives of stirene | |
DE3460620D1 (en) | Pharmaceutical or veterinary composition for the treatment of ischemic cardiac disorders | |
ZA881122B (en) | Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders | |
ZA886247B (en) | Use of a compound for the treatment of schizophrenia | |
EP0288685A3 (en) | Use of pyrrolidone derivatives as anti-amnestic agents | |
GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
EP0303232A3 (en) | Use of benzylpyridine derivatives for the treatment of dementia | |
HU8905409D0 (en) | Process for the preparation of compositions containing ace inhibitor suitable for the treatment of postischaemic cardiac disturbances | |
ZA907702B (en) | The use of alkylphosphoric acid compounds for combatting psoriasis disorders | |
GB2272155B (en) | Piperazine derivatives for treatment of cognitive disorders | |
GB2195532B (en) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
PL301188A1 (en) | Novel heterocyclic compounds, therapeutic agents containing them and method of obtaining such compounds | |
NZ255753A (en) | Use of substituted azaspiranes for psoriasis treatment | |
AU9122591A (en) | N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders | |
GB2167067B (en) | Process for stabilization of bacampicillin hydrochloride | |
EP0419135A3 (en) | Use of 1,3-di-n-butyl-7-(2-oxopropyl)xanthine for treating disorders resulting from cerebral ischemia | |
AU590608B2 (en) | Novel n-substituted 3,4 - dihydropyrimidine derivatives as agents for treating disorders of cardiovascular system | |
GB8705285D0 (en) | Treatment of psychiatric disorders |